Learn / Epidemiology / Screening and diagnostic tests
Evaluating screening and diagnostic programmes in practice
12 minute read · 6-question quiz
What you will learn
Map a diagnostic or screening pathway as a cascade and find where people are lost
Interpret programme indicators such as coverage, yield and positivity
Apply these ideas to HIV, TB and cervical cancer programmes
A test does not help anyone unless the person is reached, tested, receives the result, is linked to treatment and stays in care. Programme evaluation therefore follows the cascade from eligible people to the final outcome.
Standard indicators
| Indicator | Definition | What it shows |
| Coverage | Screened ÷ eligible | Reach |
| Positivity | Positives ÷ tested | Workload and test performance; compare across sites |
| Yield | New cases found ÷ tested | Efficiency |
| Linkage to care | Linked ÷ diagnosed (within a set time) | Success of referral |
| Retention | In care at 12 months ÷ started | Continuity |
| Turnaround time | From sample to result received | Delays that cause loss |
| Interval cancers | Cases arising between screens | Missed or fast-growing disease (sensitivity of the programme) |
The HIV 95-95-95 cascade
The UNAIDS targets are that, by 2030, 95% of all people living with HIV know their status, 95% of those diagnosed receive sustained antiretroviral therapy and 95% of those on treatment have viral suppression. Multiplying the steps: 0.95 × 0.95 × 0.95 = 0.857, so 86% of all people living with HIV would be virally suppressed. Several East and Southern African countries have reported results close to these targets in national population surveys. A shortfall at any step lowers the final figure: 90-90-90 gives only 73%.
The TB cascade
The TB care cascade from estimated incidence: people with TB who are notified (the 'missing millions' who are never diagnosed); notified who start treatment; those who complete and are cured. Tools to close the gap: community screening, symptom screening for all, Xpert and other rapid molecular tests, contact investigation and TB preventive treatment.
Summary
A screening or testing programme works through a cascade; evaluate every step.
Coverage, positivity, yield, linkage, retention and turnaround time are core indicators.
The UNAIDS 95-95-95 targets multiply to 86% viral suppression among all people living with HIV.
Losses accumulate: five steps at 90% leave 59%.
Fix the largest absolute loss first; triangulate routine data with surveys.
Check your understanding
Draft study guide. Spotted an error or something unclear? Tell us at hello@scintria.com. This is educational material, not clinical or regulatory advice.